Conformity of Fine Needle Aspiration Biopsy (FNAB) and Core Needle Biopsy (CNB) in Peripheral Lung Tumor Patients: A Cross-sectional Study

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2022 Apr 7

PMID 35386804

Authors

Isnin Anang Marhana

Kadek Widianiti

Etty Hary Kusumastuti

Affiliations

Soon will be listed here.

Abstract

Background: The problem of establishing lung tumor diagnostics is a challenge for clinicians, especially pulmonologists, in determining a definitive diagnosis of a lung tumor.

Objective: Analyzing the conformity of anatomical pathology results between fine-needle aspiration biopsy (FNAB) and core needle biopsy (CNB) materials in peripheral lung tumors.

Methods: A cross-sectional study was conducted from July 2019 to December 2020 with 66 participants. Participants were examined for CNB and FNAB, in which the results of these examinations were compared for conformity. Statistical analysis used the Kappa test with < 0.05.

Result: Most participants' tumor size was >70 mm, with FNAB results showing malignant category (39.5%), non-malignant (40.0%), and undiagnosed (38.9%; = 0.757). Meanwhile, CNB examination showed a tumor size of >70 mm that was categorized into malignant (40.4%) and non-malignant (33.3%; = 0.510). Most tumors were located in the right superior lobe that had FNAB results in the malignant (39.5%), non-malignant (30.0%) and undiagnosed (27.8%; = 0.306) categories. The CNB examination also showed that most tumors were located in the right superior lobe, which had resulted in the category of malignant (34.4%), non-malignant (26.7%), and undiagnosed (75.0%; = 0.240). Conformity of anatomical pathology results from FNAB and CNB subject such as malignancy category of 35 participants (74.5%), non-malignancy of 7 participants (53.8%) and undiagnosed of 4 participants (16.7%) with an accuracy of 69.69% ( = 0.43; = 0.001).

Conclusion: There is a conformity between the anatomical pathology results from FNAB and CNB materials for the diagnosis of lung tumors. CNB showed better results in the detection of anatomical malignancy and specimen adequacy.

Citing Articles

CT-Guided Transthoracic Core-Needle Biopsy of Pulmonary Nodules: Current Practices, Efficacy, and Safety Considerations.

Constantinescu A, Stoicescu E, Iacob R, Chira C, Cocolea D, Nicola A J Clin Med. 2024; 13(23).

PMID: 39685787 PMC: 11642045. DOI: 10.3390/jcm13237330.

Expression of MAGE A1 to MAGE A10 in the Forceps Biopsy and Bronchoalveolar Lavage Specimens from Patients with the Central Lung Tumor.

Mastutik G, Rahniayu A, Marhana I, Amin M, Ruslan S, Trianto H Asian Pac J Cancer Prev. 2024; 25(1):159-167.

PMID: 38285780 PMC: 10911746. DOI: 10.31557/APJCP.2024.25.1.159.

The MAGE A1-A10 Expression associated with Histopathological Findings of Malignant or Non-Malignant Cells in Peripheral Lung Tumors.

Mastutik G, Rahniayu A, Marhana I, Kurniassari N, Rahaju A, Amin M Asian Pac J Cancer Prev. 2023; 24(7):2329-2335.

PMID: 37505763 PMC: 10676496. DOI: 10.31557/APJCP.2023.24.7.2329.

References

Joudeh A, Shareef S, Al-Abbadi M . Fine-Needle Aspiration Followed by Core-Needle Biopsy in the Same Setting: Modifying Our Approach. Acta Cytol. 2016; 60(1):1-13. DOI: 10.1159/000444386. View

Meyer C . "Transthoracic needle aspiration biopsy of benign and malignant lung lesions"--a commentary. AJR Am J Roentgenol. 2007; 188(4):891-3. DOI: 10.2214/AJR.06.0986. View

Han B, Tjulandin S, Hagiwara K, Normanno N, Wulandari L, Laktionov K . EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study. Lung Cancer. 2017; 113:37-44. DOI: 10.1016/j.lungcan.2017.08.021. View

Schneider F, Smith M, Lane M, Pantanowitz L, Dacic S, Ohori N . Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas. Am J Clin Pathol. 2015; 143(2):193-200. DOI: 10.1309/AJCPMY8UI7WSFSYY. View

Merinda V, Soegiarto G, Wulandari L . T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors. Lung India. 2020; 37(1):13-18. PMC: 6961098. DOI: 10.4103/lungindia.lungindia_182_19. View

Manhire A, Charig M, Clelland C, Gleeson F, Miller R, Moss H . Guidelines for radiologically guided lung biopsy. Thorax. 2003; 58(11):920-36. PMC: 1746503. DOI: 10.1136/thorax.58.11.920. View

Yao X, Gomes M, Tsao M, Allen C, Geddie W, Sekhon H . Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review. Curr Oncol. 2012; 19(1):e16-27. PMC: 3267593. DOI: 10.3747/co.19.871. View

Mathew G, Agha R, Albrecht J, Goel P, Mukherjee I, Pai P . STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg. 2021; 96:106165. DOI: 10.1016/j.ijsu.2021.106165. View

Padmanabhan V, Steinmetz H, Rizzo E, Erskine A, Fairbank T, De Abreu F . Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center. Arch Pathol Lab Med. 2016; 141(3):402-409. DOI: 10.5858/arpa.2016-0096-OA. View

10.

Layfield L, Roy-Chowdhuri S, Baloch Z, Ehya H, Geisinger K, Hsiao S . Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology. Diagn Cytopathol. 2016; 44(12):1000-1009. PMC: 5590370. DOI: 10.1002/dc.23549. View

11.

Capalbo E, Peli M, Lovisatti M, Cosentino M, Mariani P, Berti E . Trans-thoracic biopsy of lung lesions: FNAB or CNB? Our experience and review of the literature. Radiol Med. 2013; 119(8):572-94. DOI: 10.1007/s11547-013-0360-1. View

12.

Coley S, Crapanzano J, Saqi A . FNA, core biopsy, or both for the diagnosis of lung carcinoma: Obtaining sufficient tissue for a specific diagnosis and molecular testing. Cancer Cytopathol. 2015; 123(5):318-26. DOI: 10.1002/cncy.21527. View

13.

Sperandeo M, Trovato F, Dimitri L, Catalano D, Simeone A, Martines G . Lung transthoracic ultrasound elastography imaging and guided biopsies of subpleural cancer: a preliminary report. Acta Radiol. 2014; 56(7):798-805. DOI: 10.1177/0284185114538424. View

14.

Yaprak Bayrak B, Paksoy N, Vural C . Diagnostic utility of fine needle aspiration cytology and core biopsy histopathology with or without immunohistochemical staining in the subtyping of the non-small cell lung carcinomas: Experience from an academic centre in Turkey. Cytopathology. 2020; 32(3):331-337. DOI: 10.1111/cyt.12937. View

15.

Wulandari L, Soegiarto G, Febriani A, Fatmawati F, Sahrun . Comparison of Detection of Epidermal Growth Factor Receptor (EFGR) Gene Mutation in Peripheral Blood Plasma (Liquid Biopsy) with Cytological Specimens in Lung Adenocarcinoma Patients. Indian J Surg Oncol. 2021; 12(Suppl 1):65-71. PMC: 8119557. DOI: 10.1007/s13193-020-01046-1. View

16.

Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C . CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol. 2003; 180(6):1665-9. DOI: 10.2214/ajr.180.6.1801665. View

17.

Chen L, Jing H, Gong Y, Tam A, Stewart J, Staerkel G . Diagnostic efficacy and molecular testing by combined fine-needle aspiration and core needle biopsy in patients with a lung nodule. Cancer Cytopathol. 2020; 128(3):201-206. DOI: 10.1002/cncy.22234. View

18.

Kendirlinan R, Ozkan G, Bayram M, Bakan N, Tutar M, Gur A . Ultrasound guided fine-needle aspiration biopsy of metastases in nonpalpable supraclavicular lymph nodes in lung cancer patients. Multidiscip Respir Med. 2012; 6(4):220-5. PMC: 3463075. DOI: 10.1186/2049-6958-6-4-220. View

19.

Yamamoto N, Watanabe T, Yamada K, Nakai T, Suzumura T, Sakagami K . Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy. J Thorac Dis. 2019; 11(3):936-943. PMC: 6462728. DOI: 10.21037/jtd.2019.01.88. View